We also found that 6 genes in stage II HCC were differentially methylated compared to that seen in stage I HCC (TRAF2, MAP2K4, NFATC2, MAPKAPK2, CDC25B, and PPP3CA; Figure 3). This evidence concerns the gene NFATC2 and hepatocellular carcinoma.